Ikena Oncology, Inc. (IKNA) Tops Q2 EPS by 8c

Ikena Oncology, Inc. (NASDAQ: IKNA) reported Q2 EPS of ($0.28), $0.08 better than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Ikena Oncology, Inc. (IKNA) click here.

You May Also Be Interested In

• AppLovin Corp (APP) PT Lowered to $510 at Evercore ISI, 'Taking a More Cautious Q4/FY27 View'
• PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
• Active options: NVDA TSLA AAPL AMZN MU SPCX PCG INTC META GOOGL